UniQure is breathing a sigh of relief after its controversial gene therapy for Huntington’s disease successfully cleared a critical regulatory hurdle. The company has...
Swiss banking giant UBS has downgraded its outlook on the Spanish construction firm Ferrovial, shifting the stock from a buy to neutral following the...
How much is international trade costing Americans jobs? It turns out, not much. A major objection by protectionists is that international trade with other...
Sam Enright works on innovation policy at Progress Ireland, an independent policy think tank in Dublin, and runs a publication called The Fitzwilliam. Most...